A Phase II Clinical Study to Evaluate the Efficacy and Safety of NS-136 in the Treatment of Schizophrenia
Clinical trial NCT07521683 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07521683
- Sponsor
- NeuShen Therapeutics
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-20
- Primary completion
- 2026-11-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.